OR WAIT null SECS
Check out the latest features and columns!
These five brands prove that pharma marketers can pull it together with compelling stories, and meaningful patient impact, even during a pandemic.
September's Executive Profile features Teva CEO Kåre Schultz
Biopharma leaders and experts gather to discuss the future of pharma collaboration and tackling critical public health needs—together.
Pharm Exec’s latest listing of the top global biopharma sales producers captures the critical business and public health balancing act that was required in the Year of COVID.
Read the profiles of 13 diverse leaders vital to the future of the biopharma industry.
With a complicated and challenging global picture greeting the new year, driven by the continuing pandemic and historic political and regulatory changes in the US and Europe, we outline eight diverse trends critical to biopharma’s future health and growth.
Highlighted Videos
September 14, 2021
Winner to Be Announced During Marketing Research and Insight Excellence Awards Virtual Ceremony on November 9.
Teva CEO Kåre Schultz talks about his long industry experience tackling major strategic and operational challenges, and how he is progressing on his current mission to turn around Teva’s fortunes.
Two of 2021 Inc. Magazine's 5,000 fastest-growing private companies unite.
When was the last time a big pharma’s shares massively outperformed a biotech index YTD? Hint: You likely weren’t around.
Vaccines spotlight recent resurgence of useful messaging tool.
Digital transformation in medical affairs made a sluggish start, but there is plenty to be optimistic about.
If not addressed, effects could impact innovation, diversity.
Treatment availability for rare disease patients under fire in Europe.
But accelerated approval program faces scrutiny.
Looking Back at 2007–2010.
